Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

NCT01749969

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Investigational Site Number 840004 San Francisco, California, United States

Investigational Site Number 840001 Tampa, Florida, United States

Investigational Site Number 840002 St Louis, Missouri, United States

Investigational Site Number 840005 New York, United States

View Trial Details

Completed

Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT

NCT05928156

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Completed

Thrombosis in Patients With Multiple Myeloma in an University Medical Center

NCT05541978

Conditions: Arterial Thromboembolism, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

NCT02204241

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations: Fondazione EMN Italy Onlus Torino, Italy

View Trial Details

Completed

Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)

NCT02185820

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dipartimento di Biotecnologie Molecolari e Scienze per la Salute Torino, Italy

View Trial Details

Completed

Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients

NCT01063179

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: A.O.U. S. Giovanni Battista Torino, Italy

View Trial Details

Completed

Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients

NCT03409692

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Turin Turin, Italy

View Trial Details

Completed

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

NCT01572662

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

NCT01160107

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations: Not specified

View Trial Details

Completed

Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide

NCT01166113

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: AOU Città della Salute e della Scienza di Torino - SC Ematologia U Torino, Italy

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions